SCHEMBL3661571

SCHEMBL3661571

COC(=O)c1cc(N)cc(-c2ccc(Cl)cn2)c1.COC(=O)c1cc(NC(=O)C(C)C)cc(-c2ccc(Cl)cn2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.41
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
RECQL P46063 1/20 0.38
ATAD2 Q6PL18 1/20 0.38
LMNA P02545 2/20 0.38
IDO1 P14902 1/20 0.38
MAPT P10636 3/20 0.37
ALDH1A1 P00352 3/20 0.37
ATM Q13315 2/20 0.37
HPGD P15428 1/20 0.37
XBP1 P17861 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GABRA5 P31644 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL358147 0.94 HSD17B10 (0.44) PTGER1HSD17B10NPC1RAB9AKMT2A
SCHEMBL357302 0.87 ATAD2 (0.47) HSD17B10NPC1RAB9AKMT2AMEN1
SCHEMBL18172328 0.78 HSD17B10 (0.50) PTGER1HSD17B10NPC1RAB9AKMT2A
SCHEMBL3655048 0.75 ATAD2 (0.45) HSD17B10NPC1RAB9AATAD2LMNA
SCHEMBL310982 0.74 ATAD2 (0.51) HSD17B10NPC1RAB9AATAD2LMNA
SCHEMBL15943023 0.74 HSD17B10 (0.43) HSD17B10LMNAIDO1KDM4E
SCHEMBL311270 0.73 GABRA5 (0.44) NPC1RAB9AKMT2AMEN1RECQL
SCHEMBL3654510 0.73 ATAD2 (0.40) NPC1RAB9AATAD2MAPTKDM4E
SCHEMBL5177009 0.72 ALDH1A1 (0.61) HSD17B10NPC1RAB9AKMT2AMEN1
SCHEMBL3061078 0.72 MEN1 (0.46) NPC1RAB9AKMT2AMEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234989-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009077371-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed